South Sudan

Medicines regulation in South Sudan is administered by the Drug and Food Control Authority (DFCA) under the national legal framework. The official government trade portal provides the DFCA procedure and institutional contact route and lists the Drug and Food Control Authority Act, 2012 among the applicable laws. Companies seeking market access should follow the official marketing-authorisation procedure and maintain appropriate arrangements for monitoring product safety after supply, documenting complaints and adverse reactions, communicating significant safety issues, and responding to DFCA requests or product-specific conditions. The official material currently accessible through these government sources does not clearly publish a comprehensive GVP guideline or universal numerical obligations for a locally resident QPPV, PSMF format or location, post-marketing ICSR timelines, fixed PSUR/PBRER frequencies, a national RMP template or a routine pharmacovigilance-inspection cycle applicable to every MAH. These points should be confirmed directly with DFCA during registration and post-authorisation maintenance. Requirements from neighbouring countries or regional initiatives should not be presented as binding South Sudanese law unless incorporated into the applicable authorisation or a national instrument. BAUPHARMA supporting resources (operational context only, not national regulatory evidence): Effective Signal Management in Pharmacovigilance.